For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Clinical trial success for young woman with multiple food allergies
+Practice
Caseload
Clinical trial success for young woman with multiple food allergies
Wednesday 23 October 2024, 12:35 AM

An egg roll was nearly the end of Annie, requiring an adrenaline pen and an ambulance to save her life [Image: Chris Tweten on Pixabay]
GP Jonathan Bentley discusses a patient with allergies to eggs, nuts and dairy. Regular use of an adrenaline pen is greatly reduced when she starts a clinical trial
Key points, Omalizumab is currently used in clinical practice for allergic asthma, chronic rhinosinusitis with nasal polyps, as well as chronic idiopathic urticar, Pract Green w Pale Yellow
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
Wood RA, Togias A, Sicherer SH, et al. Omalizumab for the treatment of multiple food allergies. N Engl J Med 2024;390(10):889-899. www.doi.org/10.1056/NEJMoa2312382